Clinical Trial Update: A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body [Phase 1]

View source ↗

Summary

Phase 1 study of BMS-986171 in healthy volunteers to assess safety, pharmacokinetics, and pharmacodynamics; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis
• Nonalcoholic Steatohepatitis

Drugs mentioned

• BMS-986171

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Liver Fibrosis/NASH | Phase 1 | Status: COMPLETED